Pathways’ Picks May 13: Frustrations with FEMA, Medicare Inpatient Rule, and More to Watch

article image

FEMA wants to set up a combined government-industry committee to support distribution of pandemic-response products, but the federal agency likely to get pushback from the device industry over antitrust concerns during a scheduled May 21 teleconference. That, technology takeaways from the just-released Medicare hospital inpatient payment proposal, and more in this week’s Pathways’ Picks.

The US Federal Emergency Management Agency wants to forge a five-year “voluntary agreement” and set up a committee, with device and drug firms, and other makers of “critical health and medical resources” for COVID-19, under the Defense Production Act. That and more in the latest Pathways’ Picks roundup.

Articles from David Filmore:

Regulatory & Reimbursement

Some Medtech Wins, Many Wait-and-Sees in Medicare Inpatient Proposal

The recently issued FY 2021 CMS inpatient proposal is the first to implement a new fast-track path to new-tech bonus payments for Breakthrough Devices, and two heart failure technologies, including the BAROSTIM NEO made the grade. The reimbursement prospects for an array of other devices remain unclear. A quick look at the recent Medicare NTAP proposals.

Read Article